Literature DB >> 6107694

Prostacyclin for pulmonary hypertension.

J Szczeklik, A Szczeklik, R Nizankowski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6107694     DOI： 10.1016/s0140-6736(80)92291-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

Review 1.  Prostaglandins and the lung.

Authors:  S P Hanley
Journal:  Lung       Date:  1986       Impact factor: 2.584

Review 2.  PGI2 as a regulator of CD4+ subset differentiation and function.

Authors:  Madison G Boswell; Weisong Zhou; Dawn C Newcomb; R Stokes Peebles
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-08-12       Impact factor: 3.072

Review 3.  Nobel lecture, 8th December 1982. Adventures and excursions in bioassay: the stepping stones to prostacyclin.

Authors:  J R Vane
Journal:  Br J Pharmacol       Date:  1983-08       Impact factor: 8.739

Review 4.  Nobel lecture. Adventures and excursions in bioassay--the stepping stones to prostacyclin.

Authors:  J R Vane
Journal:  Postgrad Med J       Date:  1983-12       Impact factor: 2.401

Review 5.  Prostaglandins and the cardiovascular system.

Authors:  J R Vane
Journal:  Br Heart J       Date:  1983-05

Review 6.  Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin.

Authors:  S Moncada
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

7.  Effects of prostaglandin E1 and other vasodilator agents in pulmonary hypertension of scleroderma.

Authors:  M Baron; G Skrinskas; R Hyland; M B Urowitz
Journal:  Br Heart J       Date:  1982-09

8.  Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man.

Authors:  H Pickles; J O'Grady
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

9.  Effect of prostacyclin on vascular capacity in the dog.

Authors:  T G Fulghum; J P DiMarco; E W Supple; I Nash; J Gendlerman; D F Eton; J B Newell; R M Zusman; W J Powell
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

10.  Prostacyclin.

Authors:  J R Vane
Journal:  J R Soc Med       Date:  1983-04       Impact factor: 18.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.